Deep Track Capital, LP - 08 Jan 2026 SCHEDULE 13G Report for Century Therapeutics, Inc. Common Stock, par value $0.0001 per share (IPSC)

Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Capital, LP
Security
Century Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
IPSC
Shares outstanding
183,738,420 shares
Disclosed Ownership
13,486,400 shares
Ownership
7.3%
Form type
SCHEDULE 13G
Filing time
15 Jan 2026, 16:13:45 UTC
Date of event
08 Jan 2026
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Capital, LP 7.3% 13,486,400 0 13,486,400 /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser
Deep Track Biotechnology Master Fund, Ltd. 5.8% 10,609,008 0 10,609,008 /s/ David Kroin David Kroin, Director
David Kroin 7.3% 13,486,400 0 13,486,400 /s/ David Kroin David Kroin
Deep Track Special Opportunities Fund, LP. 1.6% 2,877,392 0 2,877,392 /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser of Deep Track Special Opportunities Fund, LP